Suppr超能文献

食管癌三模态治疗后术后并发症的预测因素。

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

机构信息

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):885-91. doi: 10.1016/j.ijrobp.2013.04.006.

Abstract

PURPOSE

While trimodality therapy for esophageal cancer has improved patient outcomes, surgical complication rates remain high. The goal of this study was to identify modifiable factors associated with postoperative complications after neoadjuvant chemoradiation.

METHODS AND MATERIALS

From 1998 to 2011, 444 patients were treated at our institution with surgical resection after chemoradiation. Postoperative (pulmonary, gastrointestinal [GI], cardiac, wound healing) complications were recorded up to 30 days postoperatively. Kruskal-Wallis tests and χ(2) or Fisher exact tests were used to assess associations between continuous and categorical variables. Multivariate logistic regression tested the association between perioperative complications and patient or treatment factors that were significant on univariate analysis.

RESULTS

The most frequent postoperative complications after trimodality therapy were pulmonary (25%) and GI (23%). Lung capacity and the type of radiation modality used were independent predictors of pulmonary and GI complications. After adjusting for confounding factors, pulmonary and GI complications were increased in patients treated with 3-dimensional conformal radiation therapy (3D-CRT) versus intensity modulated radiation therapy (IMRT; odds ratio [OR], 2.018; 95% confidence interval [CI], 1.104-3.688; OR, 1.704; 95% CI, 1.03-2.82, respectively) and for patients treated with 3D-CRT versus proton beam therapy (PBT; OR, 3.154; 95% CI, 1.365-7.289; OR, 1.55; 95% CI, 0.78-3.08, respectively). Mean lung radiation dose (MLD) was strongly associated with pulmonary complications, and the differences in toxicities seen for the radiation modalities could be fully accounted for by the MLD delivered by each of the modalities.

CONCLUSIONS

The radiation modality used can be a strong mitigating factor of postoperative complications after neoadjuvant chemoradiation.

摘要

目的

尽管食管癌的三联疗法改善了患者的预后,但手术并发症发生率仍然很高。本研究的目的是确定与新辅助放化疗后术后并发症相关的可改变因素。

方法和材料

1998 年至 2011 年,我们机构对 444 例接受放化疗后手术切除的患者进行了治疗。术后(肺部、胃肠道[GI]、心脏、伤口愈合)并发症在术后 30 天内记录。Kruskal-Wallis 检验和 χ(2)或 Fisher 确切概率检验用于评估连续变量和分类变量之间的关系。多变量逻辑回归检验了围手术期并发症与单变量分析中显著的患者或治疗因素之间的关系。

结果

三联疗法后最常见的术后并发症是肺部(25%)和胃肠道(23%)。肺容量和使用的放射治疗方式是肺部和胃肠道并发症的独立预测因素。调整混杂因素后,与调强适形放射治疗(IMRT)相比,接受三维适形放射治疗(3D-CRT)治疗的患者肺部和胃肠道并发症增加(比值比[OR],2.018;95%置信区间[CI],1.104-3.688;OR,1.704;95% CI,1.03-2.82),与质子束治疗(PBT)相比,接受 3D-CRT 治疗的患者肺部和胃肠道并发症也增加(OR,3.154;95% CI,1.365-7.289;OR,1.55;95% CI,0.78-3.08)。平均肺辐射剂量(MLD)与肺部并发症密切相关,每种放射治疗方式的毒性差异可完全由各方式的 MLD 来解释。

结论

放射治疗方式是新辅助放化疗后术后并发症的一个重要缓解因素。

相似文献

3
A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients.多机构分析老年食管癌的三联治疗。
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):820-828. doi: 10.1016/j.ijrobp.2017.02.021. Epub 2017 Feb 20.

引用本文的文献

本文引用的文献

1
Physiological interaction of heart and lung in thoracic irradiation.胸部放疗中心肺的生理相互作用。
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):e639-46. doi: 10.1016/j.ijrobp.2012.07.2362. Epub 2012 Sep 11.
5
Proton beam therapy and concurrent chemotherapy for esophageal cancer.质子束疗法联合化疗治疗食管癌。
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e345-51. doi: 10.1016/j.ijrobp.2012.01.003. Epub 2012 Mar 13.
7
Prediction of major pulmonary complications after esophagectomy.食管癌术后主要肺部并发症的预测。
Ann Thorac Surg. 2011 May;91(5):1494-1500; discussion 1500-1. doi: 10.1016/j.athoracsur.2010.12.036.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验